Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05322213 · ClinicalTrials.gov registry record · Phase 1

THC Effects on Glucose in Type 2 Diabetes

A Phase 1 study of Type 2 Diabetes, sponsored by University of California, San Diego.

Recruiting
Registry status
Phase 1
Development phase
30
Enrollment target
1
Study location

NCT05322213 is a Phase 1 study of Type 2 Diabetes that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 30 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05322213, a Phase 1 study of Type 2 Diabetes, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
Phase 1
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study will examine the effects THC has on Glucose Metabolism and Endothelial Functioning in participants with Type 2 Diabetes. The participants will complete blood tests and tests to measure energy expenditure, CVD risks, and glucose metabolism. These tests will be performed prior to start of treatment and again after 2-weeks of treatment with the THC or placebo.

Conditions Studied

Type 2 Diabetes

Interventions

  • DRUG Placebo
  • DRUG THC

Study Locations (1)

California

  • UC San Diego Altman Clinical & Translational Research Institute - La Jolla

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-08-22
Est. Completion 2028-06
Phase Phase 1

Sponsor

University of California, San Diego

775 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05322213

The ClinicalTrials.gov registry entry for NCT05322213 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05322213 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05322213 about?

NCT05322213 is a clinical study titled "THC Effects on Glucose in Type 2 Diabetes". This study will examine the effects THC has on Glucose Metabolism and Endothelial Functioning in participants with Type 2 Diabetes. The participants will complete blood tests and tests to measure energy expenditure, CVD risks, and glucose metabolism. These tests will be performed prior to start of t...

What is the current status of trial NCT05322213?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2024-08-22. Estimated completion is 2028-06.

What conditions does trial NCT05322213 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT05322213?

The interventions under investigation include: Placebo (DRUG), THC (DRUG).

Who is sponsoring clinical trial NCT05322213?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05322213 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 2 Diabetes

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.